Aleafia, Serruya Family Extend Exclusivity Period for Retail and Brand Joint-Venture
10 October 2018 - 10:05PM
Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH)
(“Aleafia”) or (the “Company”), has extended the exclusivity period
for the proposed adult-use retail and brands
joint-venture (“JV”) with the Serruya Family (the
“Serruya Family”), by two weeks.
The JV marks the first phase of a multiphase strategy that will
see Aleafia enter the adult-use cannabis industry and related
retail operations in Canada and globally. This will
create the foundation for the adult-use business pillar, joining
Aleafia’s two existing business pillars - cannabis cultivation and
medical clinic operations.
Aleafia Operational Update:
- Fully funded annual growing capacity of 98,000 kg of cannabis
flower in 2019
- 160,000 sq. ft. Niagara greenhouse retrofitting on schedule and
expected to be complete in late 2018
- Reached milestone of 50,000 medical cannabis patients
- Secured first medical cannabis sale in company’s history, only
days after securing Sales Licence from Health Canada
For Investor & Media Relations, please
contact:
Nicholas Bergamini, VP Public Affairs IR@AleafiaInc.com
About Aleafia Health Inc.:
Aleafia is a leading, vertically integrated cannabis company
with major cannabis cultivation & processing and medical
cannabis clinics business operations. Aleafia owns two cannabis
cultivation facilities, one of which is licensed and fully
operational and one which will be fully operational in late 2018.
Aleafia will reach a fully-funded annual growing capacity of 98,000
kg in 2019. Canabo Medical Clinics are the largest brick and mortar
medical cannabis clinic network in Canada with 22 locations and
over 50,000 patients.
Neither Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and
information that are based on the beliefs of management and reflect
the Company's current expectations. When used in this press
release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the
negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and
information. The forward-looking statements and information
in this press release includes information relating to the
implementation of Aleafia Health's business plan. Such
statements and information reflect the current view of the Company
with respect to risks and uncertainties that may cause actual
results to differ materially from those contemplated in those
forward-looking statements and information.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements, or other future
events, to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among
others, the following risks: risks associated with the
implementation of Aleafia Health's business plan and matters
relating thereto, risks associated with the cannabis industry,
competition, regulatory change, the need for additional financing,
reliance on key personnel, the potential for conflicts of interest
among certain officers or directors, and the volatility of the
Company's common share price and volume. Forward-looking
statements are made based on management's beliefs, estimates and
opinions on the date that statements are made and the Company
undertakes no obligation to update forward-looking statements if
these beliefs, estimates and opinions or other circumstances should
change. Investors are cautioned against attributing undue
certainty to forward-looking statements.
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Jul 2023 to Jul 2024